Report cover image

Global Tumor Fluid Biopsy Market Analysis and Forecast 2025-2031

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 194 Pages
SKU # APRC20361683

Description

Summary

According to APO Research, The global Tumor Fluid Biopsy market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Tumor Fluid Biopsy is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Tumor Fluid Biopsy is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Tumor Fluid Biopsy is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Tumor Fluid Biopsy is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Tumor Fluid Biopsy include Cellmax Life, Exact Science, Amoy Diagnostics Co, Berry Genomics Co, Genetronhealth, GenoploRare, HaploX Biotechnology Co, New Horizon Health Limited and Burning Rock Biotech, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Tumor Fluid Biopsy, market size. Analyses of the global market trends, with historic market revenue data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Tumor Fluid Biopsy, also provides the revenue of main regions and countries. Of the upcoming market potential for Tumor Fluid Biopsy, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Tumor Fluid Biopsy revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Tumor Fluid Biopsy market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2020 to 2031. Evaluation and forecast the market size for Tumor Fluid Biopsy revenue, projected growth trends, production technology, application and end-user industry.

Tumor Fluid Biopsy Segment by Company

Cellmax Life
Exact Science
Amoy Diagnostics Co
Berry Genomics Co
Genetronhealth
GenoploRare
HaploX Biotechnology Co
New Horizon Health Limited
Burning Rock Biotech
Guangzhou Wondfo Biotech
YZY Biopharma
Tumor Fluid Biopsy Segment by Type

CTDNA Detection
CTC Detection
Other
Tumor Fluid Biopsy Segment by Application

Hospital
Third Party Organization
Other
Tumor Fluid Biopsy Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tumor Fluid Biopsy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Tumor Fluid Biopsy and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tumor Fluid Biopsy.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Tumor Fluid Biopsy in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Tumor Fluid Biopsy company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Tumor Fluid Biopsy revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.

Table of Contents

194 Pages
1 Market Overview
1.1 Product Definition
1.2 Tumor Fluid Biopsy Market by Type
1.2.1 Global Tumor Fluid Biopsy Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 CTDNA Detection
1.2.3 CTC Detection
1.2.4 Other
1.3 Tumor Fluid Biopsy Market by Application
1.3.1 Global Tumor Fluid Biopsy Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Third Party Organization
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Tumor Fluid Biopsy Market Dynamics
2.1 Tumor Fluid Biopsy Industry Trends
2.2 Tumor Fluid Biopsy Industry Drivers
2.3 Tumor Fluid Biopsy Industry Opportunities and Challenges
2.4 Tumor Fluid Biopsy Industry Restraints
3 Global Growth Perspective
3.1 Global Tumor Fluid Biopsy Market Perspective (2020-2031)
3.2 Global Tumor Fluid Biopsy Growth Trends by Region
3.2.1 Global Tumor Fluid Biopsy Market Size by Region: 2020 VS 2024 VS 2031
3.2.2 Global Tumor Fluid Biopsy Market Size by Region (2020-2025)
3.2.3 Global Tumor Fluid Biopsy Market Size by Region (2026-2031)
4 Competitive Landscape by Players
4.1 Global Tumor Fluid Biopsy Revenue by Players
4.1.1 Global Tumor Fluid Biopsy Revenue by Players (2020-2025)
4.1.2 Global Tumor Fluid Biopsy Revenue Market Share by Players (2020-2025)
4.1.3 Global Tumor Fluid Biopsy Players Revenue Share Top 10 and Top 5 in 2024
4.2 Global Tumor Fluid Biopsy Key Players Ranking, 2023 VS 2024 VS 2025
4.3 Global Tumor Fluid Biopsy Key Players Headquarters & Area Served
4.4 Global Tumor Fluid Biopsy Players, Product Type & Application
4.5 Global Tumor Fluid Biopsy Players Establishment Date
4.6 Market Competitive Analysis
4.6.1 Global Tumor Fluid Biopsy Market CR5 and HHI
4.6.3 2024 Tumor Fluid Biopsy Tier 1, Tier 2, and Tier 3
5 Tumor Fluid Biopsy Market Size by Type
5.1 Global Tumor Fluid Biopsy Revenue by Type (2020 VS 2024 VS 2031)
5.2 Global Tumor Fluid Biopsy Revenue by Type (2020-2031)
5.3 Global Tumor Fluid Biopsy Revenue Market Share by Type (2020-2031)
6 Tumor Fluid Biopsy Market Size by Application
6.1 Global Tumor Fluid Biopsy Revenue by Application (2020 VS 2024 VS 2031)
6.2 Global Tumor Fluid Biopsy Revenue by Application (2020-2031)
6.3 Global Tumor Fluid Biopsy Revenue Market Share by Application (2020-2031)
7 Company Profiles
7.1 Cellmax Life
7.1.1 Cellmax Life Comapny Information
7.1.2 Cellmax Life Business Overview
7.1.3 Cellmax Life Tumor Fluid Biopsy Revenue and Gross Margin (2020-2025)
7.1.4 Cellmax Life Tumor Fluid Biopsy Product Portfolio
7.1.5 Cellmax Life Recent Developments
7.2 Exact Science
7.2.1 Exact Science Comapny Information
7.2.2 Exact Science Business Overview
7.2.3 Exact Science Tumor Fluid Biopsy Revenue and Gross Margin (2020-2025)
7.2.4 Exact Science Tumor Fluid Biopsy Product Portfolio
7.2.5 Exact Science Recent Developments
7.3 Amoy Diagnostics Co
7.3.1 Amoy Diagnostics Co Comapny Information
7.3.2 Amoy Diagnostics Co Business Overview
7.3.3 Amoy Diagnostics Co Tumor Fluid Biopsy Revenue and Gross Margin (2020-2025)
7.3.4 Amoy Diagnostics Co Tumor Fluid Biopsy Product Portfolio
7.3.5 Amoy Diagnostics Co Recent Developments
7.4 Berry Genomics Co
7.4.1 Berry Genomics Co Comapny Information
7.4.2 Berry Genomics Co Business Overview
7.4.3 Berry Genomics Co Tumor Fluid Biopsy Revenue and Gross Margin (2020-2025)
7.4.4 Berry Genomics Co Tumor Fluid Biopsy Product Portfolio
7.4.5 Berry Genomics Co Recent Developments
7.5 Genetronhealth
7.5.1 Genetronhealth Comapny Information
7.5.2 Genetronhealth Business Overview
7.5.3 Genetronhealth Tumor Fluid Biopsy Revenue and Gross Margin (2020-2025)
7.5.4 Genetronhealth Tumor Fluid Biopsy Product Portfolio
7.5.5 Genetronhealth Recent Developments
7.6 GenoploRare
7.6.1 GenoploRare Comapny Information
7.6.2 GenoploRare Business Overview
7.6.3 GenoploRare Tumor Fluid Biopsy Revenue and Gross Margin (2020-2025)
7.6.4 GenoploRare Tumor Fluid Biopsy Product Portfolio
7.6.5 GenoploRare Recent Developments
7.7 HaploX Biotechnology Co
7.7.1 HaploX Biotechnology Co Comapny Information
7.7.2 HaploX Biotechnology Co Business Overview
7.7.3 HaploX Biotechnology Co Tumor Fluid Biopsy Revenue and Gross Margin (2020-2025)
7.7.4 HaploX Biotechnology Co Tumor Fluid Biopsy Product Portfolio
7.7.5 HaploX Biotechnology Co Recent Developments
7.8 New Horizon Health Limited
7.8.1 New Horizon Health Limited Comapny Information
7.8.2 New Horizon Health Limited Business Overview
7.8.3 New Horizon Health Limited Tumor Fluid Biopsy Revenue and Gross Margin (2020-2025)
7.8.4 New Horizon Health Limited Tumor Fluid Biopsy Product Portfolio
7.8.5 New Horizon Health Limited Recent Developments
7.9 Burning Rock Biotech
7.9.1 Burning Rock Biotech Comapny Information
7.9.2 Burning Rock Biotech Business Overview
7.9.3 Burning Rock Biotech Tumor Fluid Biopsy Revenue and Gross Margin (2020-2025)
7.9.4 Burning Rock Biotech Tumor Fluid Biopsy Product Portfolio
7.9.5 Burning Rock Biotech Recent Developments
7.10 Guangzhou Wondfo Biotech
7.10.1 Guangzhou Wondfo Biotech Comapny Information
7.10.2 Guangzhou Wondfo Biotech Business Overview
7.10.3 Guangzhou Wondfo Biotech Tumor Fluid Biopsy Revenue and Gross Margin (2020-2025)
7.10.4 Guangzhou Wondfo Biotech Tumor Fluid Biopsy Product Portfolio
7.10.5 Guangzhou Wondfo Biotech Recent Developments
7.11 YZY Biopharma
7.11.1 YZY Biopharma Comapny Information
7.11.2 YZY Biopharma Business Overview
7.11.3 YZY Biopharma Tumor Fluid Biopsy Revenue and Gross Margin (2020-2025)
7.11.4 YZY Biopharma Tumor Fluid Biopsy Product Portfolio
7.11.5 YZY Biopharma Recent Developments
8 North America
8.1 North America Tumor Fluid Biopsy Revenue (2020-2031)
8.2 North America Tumor Fluid Biopsy Revenue by Type (2020-2031)
8.2.1 North America Tumor Fluid Biopsy Revenue by Type (2020-2025)
8.2.2 North America Tumor Fluid Biopsy Revenue by Type (2026-2031)
8.3 North America Tumor Fluid Biopsy Revenue Share by Type (2020-2031)
8.4 North America Tumor Fluid Biopsy Revenue by Application (2020-2031)
8.4.1 North America Tumor Fluid Biopsy Revenue by Application (2020-2025)
8.4.2 North America Tumor Fluid Biopsy Revenue by Application (2026-2031)
8.5 North America Tumor Fluid Biopsy Revenue Share by Application (2020-2031)
8.6 North America Tumor Fluid Biopsy Revenue by Country
8.6.1 North America Tumor Fluid Biopsy Revenue by Country (2020 VS 2024 VS 2031)
8.6.2 North America Tumor Fluid Biopsy Revenue by Country (2020-2025)
8.6.3 North America Tumor Fluid Biopsy Revenue by Country (2026-2031)
8.6.4 United States
8.6.5 Canada
9 Europe
9.1 Europe Tumor Fluid Biopsy Revenue (2020-2031)
9.2 Europe Tumor Fluid Biopsy Revenue by Type (2020-2031)
9.2.1 Europe Tumor Fluid Biopsy Revenue by Type (2020-2025)
9.2.2 Europe Tumor Fluid Biopsy Revenue by Type (2026-2031)
9.3 Europe Tumor Fluid Biopsy Revenue Share by Type (2020-2031)
9.4 Europe Tumor Fluid Biopsy Revenue by Application (2020-2031)
9.4.1 Europe Tumor Fluid Biopsy Revenue by Application (2020-2025)
9.4.2 Europe Tumor Fluid Biopsy Revenue by Application (2026-2031)
9.5 Europe Tumor Fluid Biopsy Revenue Share by Application (2020-2031)
9.6 Europe Tumor Fluid Biopsy Revenue by Country
9.6.1 Europe Tumor Fluid Biopsy Revenue by Country (2020 VS 2024 VS 2031)
9.6.2 Europe Tumor Fluid Biopsy Revenue by Country (2020-2025)
9.6.3 Europe Tumor Fluid Biopsy Revenue by Country (2026-2031)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Netherlands
10 China
10.1 China Tumor Fluid Biopsy Revenue (2020-2031)
10.2 China Tumor Fluid Biopsy Revenue by Type (2020-2031)
10.2.1 China Tumor Fluid Biopsy Revenue by Type (2020-2025)
10.2.2 China Tumor Fluid Biopsy Revenue by Type (2026-2031)
10.3 China Tumor Fluid Biopsy Revenue Share by Type (2020-2031)
10.4 China Tumor Fluid Biopsy Revenue by Application (2020-2031)
10.4.1 China Tumor Fluid Biopsy Revenue by Application (2020-2025)
10.4.2 China Tumor Fluid Biopsy Revenue by Application (2026-2031)
10.5 China Tumor Fluid Biopsy Revenue Share by Application (2020-2031)
11 Asia (Excluding China)
11.1 Asia Tumor Fluid Biopsy Revenue (2020-2031)
11.2 Asia Tumor Fluid Biopsy Revenue by Type (2020-2031)
11.2.1 Asia Tumor Fluid Biopsy Revenue by Type (2020-2025)
11.2.2 Asia Tumor Fluid Biopsy Revenue by Type (2026-2031)
11.3 Asia Tumor Fluid Biopsy Revenue Share by Type (2020-2031)
11.4 Asia Tumor Fluid Biopsy Revenue by Application (2020-2031)
11.4.1 Asia Tumor Fluid Biopsy Revenue by Application (2020-2025)
11.4.2 Asia Tumor Fluid Biopsy Revenue by Application (2026-2031)
11.5 Asia Tumor Fluid Biopsy Revenue Share by Application (2020-2031)
11.6 Asia Tumor Fluid Biopsy Revenue by Country
11.6.1 Asia Tumor Fluid Biopsy Revenue by Country (2020 VS 2024 VS 2031)
11.6.2 Asia Tumor Fluid Biopsy Revenue by Country (2020-2025)
11.6.3 Asia Tumor Fluid Biopsy Revenue by Country (2026-2031)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 Taiwan
11.6.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA Tumor Fluid Biopsy Revenue (2020-2031)
12.2 SAMEA Tumor Fluid Biopsy Revenue by Type (2020-2031)
12.2.1 SAMEA Tumor Fluid Biopsy Revenue by Type (2020-2025)
12.2.2 SAMEA Tumor Fluid Biopsy Revenue by Type (2026-2031)
12.3 SAMEA Tumor Fluid Biopsy Revenue Share by Type (2020-2031)
12.4 SAMEA Tumor Fluid Biopsy Revenue by Application (2020-2031)
12.4.1 SAMEA Tumor Fluid Biopsy Revenue by Application (2020-2025)
12.4.2 SAMEA Tumor Fluid Biopsy Revenue by Application (2026-2031)
12.5 SAMEA Tumor Fluid Biopsy Revenue Share by Application (2020-2031)
12.6 SAMEA Tumor Fluid Biopsy Revenue by Country
12.6.1 SAMEA Tumor Fluid Biopsy Revenue by Country (2020 VS 2024 VS 2031)
12.6.2 SAMEA Tumor Fluid Biopsy Revenue by Country (2020-2025)
12.6.3 SAMEA Tumor Fluid Biopsy Revenue by Country (2026-2031)
12.6.4 Brazil
12.6.5 Argentina
12.6.6 Chile
12.6.7 Colombia
12.6.8 Peru
12.6.9 Saudi Arabia
12.6.10 Israel
12.6.11 UAE
12.6.12 Turkey
12.6.13 Iran
12.6.14 Egypt
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.